Cite
HARVARD Citation
Curtit, E. et al. (n.d.). Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis. European journal of cancer. pp. S59-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Curtit, E. et al. (n.d.). Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis. European journal of cancer. pp. S59-. [Online].